Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory
All Press Releases for November 29, 2006 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Medicine Prescription Chantix is a blockbuster
Chantix has provided with great results in comparison to other smoking cessation drugs along with no drug abuse associated with it. 
x-small text small text medium text large text


    /24-7PressRelease/ - NEW YORK, NY, November 29, 2006 - In the U.S. smoking remains the biggest cause of death and nearly 70 percent of the people smoking in the nation say that they really want to quit smoking. The astonishing fact remains that the treatments that exist work poorly whereas Chantix has shown superior performance.

Until now estimates figure out that Chantix may account for more than $1 billion of sales in a year and these sales rose up to $33 million while the drug was launched during the days in summer. The results of Chantix are found to be striking because in spite of the fact that it has very little marketing support from the company and other related criticism of the drugs, it was made advertised directly to the consumers until they have been marketed for a period of six months.

Chantix works by deadening cravings for cigarettes and blocking the effects of nicotine on the brain. The FDA approved Chantix in just six months, citing its "significant potential" to improve public health. In clinical tests sponsored by Pfizer, more than 40 percent of Chantix users were smoke-free at 12 weeks, compared with about 30 percent taking Zyban, an antidepressant sold as an aid to smoking cessation. After a year, the smoke-free Chantix users slipped to about 20 percent, not significantly better than Zyban's results but still twice as good as the results of those taking a placebo.

According to Dr. Rodriguez who has prescribed Chantix to four of its patients prefers it in comparison to Zyban as patients who tried Chantix found it extremely helpful. Unlike the nicotine-replacement, products or anti-anxiety drugs long prescribed for smokers trying to quit, Chantix works by binding to the same receptors in your brain that nicotine does, decreasing cravings for cigarettes.

Please do visit our website http://www.benzer11.com/chantix.html to know more about chantix medicine.

About Benzer11.com
Benzer11.com has a team of committed pharmacists who are quite professional for their principals and values and lead a team of branch colleagues within their community.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #


Read more Press Releases from Olivia Andrews:
Other Press Release Headlines:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Olivia Andrews
www.benzer11.com

Writer
Binghamton, NY
New York, New York
USA 13902
Voice: (607) 722-1734
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.